Drug Approval | May 10, 2024
Alembic Pharmaceuticals receives 5 USFDA product approvals in Q1 FY25
Receives 3 final and 2 tentative product approvals thus far in Q1FY25
Receives 3 final and 2 tentative product approvals thus far in Q1FY25
Aptar Closures’ E-Disc Top securely protects against in-transit leakage while eliminating the need for liners and extra shipping preparation fees
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
The CALINA study tested a new ratio and dose of Coartem to account for metabolic differences in babies under 5 kg
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
Natco Pharma intends to defend the matter accordingly
SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva
Subscribe To Our Newsletter & Stay Updated
